IDH2 and oligodendroglioma: TP53 mutational status can help to differentiate between IDH-mutant infiltrating astrocytoma and oligodendroglioma in cases where the presence of 1p/19q co-deletion is either not available or unclear in the setting of complex copy number alterations.